Loading...
Ketoconazole and the newer agent fluconazole are both effective treatments for candida esophagitis in patients with AIDS. This multicenter double-blind trial compared clinical responses and endoscopic findings with the two antifungal drugs.
Researchers randomized 169 AIDS patients with endoscopically proven candida esophagitis to receive either oral ketoconazole (200 mg/day) or fluconazole (100 mg/day); doses were doubled after one or two weeks if necessary. Among 129 patients who underwent endoscopy after treatment, endoscopic cure was observed in 91 percent of the fluconazole group and 52 percent of the ketoconazole group -- a significant difference. Symptomatic resolution was also significantly more common with fluconazole than ketoconazo…